201 related articles for article (PubMed ID: 22032915)
1. Adiponectin in outpatients with coronary artery disease: independent predictors and relationship with heart failure.
Baldasseroni S; Mannucci E; Orso F; Di Serio C; Pratesi A; Bartoli N; Marella GA; Colombi C; Foschini A; Valoti P; Mossello E; Fumagalli S; Marchionni N; Tarantini F
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):292-9. PubMed ID: 22032915
[TBL] [Abstract][Full Text] [Related]
2. Resistin level in coronary artery disease and heart failure: the central role of kidney function.
Baldasseroni S; Mannucci E; Di Serio C; Orso F; Bartoli N; Mossello E; Foschini A; Monami M; Valoti P; Fumagalli S; Colombi C; Pellerito S; Gensini G; Marchionni N; Tarantini F
J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):150-7. PubMed ID: 22240747
[TBL] [Abstract][Full Text] [Related]
3. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
[TBL] [Abstract][Full Text] [Related]
4. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide.
McEntegart MB; Awede B; Petrie MC; Sattar N; Dunn FG; MacFarlane NG; McMurray JJ
Eur Heart J; 2007 Apr; 28(7):829-35. PubMed ID: 17403719
[TBL] [Abstract][Full Text] [Related]
5. Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease.
Dini FL; Buralli S; Bajraktari G; Elezi S; Duranti E; Metelli MR; Carpi A; Taddei S
Biomed Pharmacother; 2010 May; 64(5):339-42. PubMed ID: 19944559
[TBL] [Abstract][Full Text] [Related]
6. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure.
Tsutamoto T; Tanaka T; Sakai H; Ishikawa C; Fujii M; Yamamoto T; Horie M
Eur Heart J; 2007 Jul; 28(14):1723-30. PubMed ID: 17507366
[TBL] [Abstract][Full Text] [Related]
7. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
[TBL] [Abstract][Full Text] [Related]
8. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure.
Lindberg S; Jensen JS; Bjerre M; Pedersen SH; Frystyk J; Flyvbjerg A; Mogelvang R
Eur J Heart Fail; 2014 Jun; 16(6):633-8. PubMed ID: 24723498
[TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P
Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772
[TBL] [Abstract][Full Text] [Related]
10. BNP in overweight and obese patients with heart failure: an analysis based on the BNP-LV diastolic wall stress relationship.
Iwanaga Y; Kihara Y; Niizuma S; Noguchi T; Nonogi H; Kita T; Goto Y
J Card Fail; 2007 Oct; 13(8):663-7. PubMed ID: 17923359
[TBL] [Abstract][Full Text] [Related]
11. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
[TBL] [Abstract][Full Text] [Related]
12. Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.
Sung SH; Chuang SY; Sheu WH; Lee WJ; Chou P; Chen CH
Am J Cardiol; 2009 May; 103(10):1411-6. PubMed ID: 19427438
[TBL] [Abstract][Full Text] [Related]
13. Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.
Sueta CA; Massing MW; Chowdhury M; Biggs DP; Simpson RJ
J Card Fail; 2003 Feb; 9(1):36-41. PubMed ID: 12612871
[TBL] [Abstract][Full Text] [Related]
14. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
15. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
[TBL] [Abstract][Full Text] [Related]
16. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
[TBL] [Abstract][Full Text] [Related]
17. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
[TBL] [Abstract][Full Text] [Related]
18. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
Egstrup M; Schou M; Tuxen CD; Kistorp CN; Hildebrandt PR; Gustafsson F; Faber J; Goetze JP; Gustafsson I
Am J Cardiol; 2012 Aug; 110(4):552-7. PubMed ID: 22579083
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
20. Is plasma N-BNP a good indicator of the functional reserve of failing hearts? The FRESH-BNP study.
Williams SG; Ng LL; O'Brien RJ; Taylor S; Wright DJ; Tan LB
Eur J Heart Fail; 2004 Dec; 6(7):891-900. PubMed ID: 15556051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
